Single-center experience using anakinra for steroid-refractory immune effector cell-associated neurotoxicity syndrome (ICANS)

• Marc Wehrli,
• Marcela V Maus,
• Matthew J Frigault,
• Mark B Leick,
• Nora Horick,
• Paul O'Donnell,
• Kathleen Gallagher,
• Yi-Bin Chen,
• Steven L McAfee,
• Areej R El-Jawahri,
• Zachariah DeFilipp,
• Thomas Spitzer,
• Bimal Dey,
• Daniella Cook,
• Michael Trailor,
• Kevin Lindell

Affiliations

Marc Wehrli

Aff1 grid.5734.50000000107265157Institute of PharmacologyUniversity of Bern Bern Switzerland

Marcela V Maus

7 Cellular Immunotherapy Program and Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA

Matthew J Frigault

10 Bone Marrow Transplant and Cellular Immunotherapy Program, Massachusetts General Hospital, Boston, Massachusetts, USA

Mark B Leick

Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA

Nora Horick

Harvard Medical School, Boston, MA, USA

Paul O'Donnell

University of Manchester, Manchester, UK

Kathleen Gallagher

Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts, USA

Yi-Bin Chen

Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts, USA

Steven L McAfee

Harvard Medical School, Boston, MA, USA

Areej R El-Jawahri

Harvard Medical School, Boston, MA, USA

Zachariah DeFilipp

Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts, USA

Thomas Spitzer

Harvard Medical School, Boston, MA, USA

Bimal Dey

Harvard Medical School, Boston, MA, USA

Daniella Cook

Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts, USA

Michael Trailor

Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts, USA

Kevin Lindell

Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts, USA